Ribometrix Announces $30 Million Series A Funding to Advance Pipeline of RNA-Targeting Small Molecule Therapies

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2qIRPMa
via IFTTT